ZHICANG
Zhicang specializes in providing machine learning technology and operations research algorithm for logistics companies. The platform aims to solve vehicle routing problem, 3-dimentional packing problem and other mixed problem in logistics industry.
ZHICANG
Social Links:
Industry:
Information Technology Machine Learning
Founded:
2016-01-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.heptax.com
Total Employee:
11+
Status:
Active
Technology used in webpage:
SPF Content Delivery Network CrUX Top 50m CrUX Dataset Java EE Alibaba HiChina DNS Nginx 1.12 Alibaba Cloud MailBox Tencent Cloud
Similar Organizations
AI Hayabusa
AI Hayabusa specializes in visual inspection and existing image processing using machine learning technology.
ConMagi
ConMagi specializes in providing solutions in machine learning and data mining.
Quiota
Quiota provides machine learning technology.
SCHOL
SCHOL provides solutions using distributed ledger technology and machine learning technology.
Current Employees Featured
Founder
Investors List
Albatross Venture
Albatross Venture investment in Seed Round - Zhicang
Official Site Inspections
http://www.heptax.com Semrush global rank: 2.81 M Semrush visits lastest month: 5.97 K
- Host name: 60.205.194.184
- IP address: 60.205.194.184
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Zhicang"
HepaTx
Using regenerative medicine technologies, HepaTx is developing new types of treatments, based on stem cells, to bring new therapies to patients with late stage liver disease, as an alternative …See details»
HepaTx - Crunchbase Company Profile & Funding
HepaTx closed its last funding round on May 20, 2021 from a Seed round. Who are HepaTx 's competitors? Alternatives and possible competitors to HepaTx may include Slingshot …See details»
About HepaTx — HepaTx
The HepaTx pipeline spans initial niche indications with lower developmental costs, rapid regulatory approval paths and large market chronic liver disease indications. A1ATD: Alpha 1 anti-trypsin deficiency PKU: Phenylketonuria …See details»
hepatx.com Reviews: Is this site a scam or legit?
This term indicates whether hepatx.com has landed on any online directories' blacklists and earned a suspicious tag. Assessing HTTPS Connectivity. This section provides insight into …See details»
Intro — HepaTx
ABOUT HEPATX. STRATEGY TEAM CAREERS SCIENCE MEDIA CONTACT US Intro . Off-the-shelf cell therapies for liver disease. HepaTx Awarded 2022 Impact Company of The Year …See details»
HepaTx Enters Collaboration with Mayo Clinic to …
PALO ALTO, Calif., Sept. 10, 2024 /PRNewswire/ -- HepaTx, a biotechnology company specializing in regenerative medicine, has entered into a license agreement with Mayo Clinic to advance HepaTx's ...See details»
HepaTx - Funding, Financials, Valuation & Investors - Crunchbase
Hepatx is developing regenerative medicine solutions. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log In. Organization. …See details»
HepaTx Enters Collaboration with Mayo Clinic to …
Sep 10, 2024 HepaTx, a biotechnology company specializing in regenerative medicine, has entered into a license agreement with Mayo Clinic to advance HepaTx's innovative stem cell technology into clinical trials.See details»
HepaTx - Contacts, Employees, Board Members, Advisors
Hepatx is developing regenerative medicine solutions. Unlock even more features with Crunchbase ProSee details»
HepaTx Enters Collaboration with Mayo Clinic to Advance Cell …
Sep 10, 2024 I can think of no better organization to work with given their outstanding liver disease and regenerative medicine expertise,” commented Eric Schuur, the CEO of HepaTx. …See details»
HepaTx Company Profile 2024: Valuation, Funding & Investors
HepaTx General Information Description. Developer of a stem cell-based therapy designed to replace liver transplants as a treatment for liver failure. The company's therapies are based on …See details»
HEPATX CORPORATION Company Profile - Dun & Bradstreet
Hepatx corporation. d&b business directory home / business directory / professional, scientific, and technical services / scientific research and development services / united states / …See details»
Hepatx Corp. - Drug pipelines, Patents, Clinical trials - Synapse
HepaTx’s approach to developing an off-the-shelf cell therapy to treat patients with serious liver disease is unique in that HepaTx does not genetically modify its cells, it uses adipose tissue as …See details»
SCIENCE — HepaTx
Until now, organ transplant has been the one and only efficacious therapy to save hundreds of vital functions for thousands of lives. It is a successful procedure, but its availability is …See details»
HepaTx Company Profile - Office Locations, Competitors, Revenue …
HepaTx $2.1 m in total funding,. See insights on HepaTx including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
HepaTX - Products, Competitors, Financials, Employees, …
HepaTx Enters Collaboration with Mayo Clinic to Advance Cell Therapy Technology for Liver Disease to Clinical Trials. Sep 10, 2024. News provided by Share this article Share toX PALO …See details»
Hepatx Corporation Company Profile | Palo Alto, CA | Competitors ...
Hepatx Corporation. Website. Get a D&B Hoovers Free Trial. Overview Company Description:? Key Principal: Eric Schuur See more contacts Industry: Scientific Research and Development …See details»
HepaTx - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Hepatx is developing regenerative medicine solutions. Start Free Trial . Chrome ExtensionSee details»
Hepatx Corporation - VentureRadar
" HepaTx is a biotechnology company focused on developing off-the-shelf cell therapies for liver disease. Utilizing regenerative medicine technologies, the firm creates stem-cell-based …See details»
MEET THE TEAM - HepaTx
Dr. Avnesh S Thakor Scientific Advisor. Dr Thakor is an adult and pediatric-certified Interventional Radiologist whose vision and research are focused on developing the area of "Precision …See details»